1-4 of 4
Pedro Gascón
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract LB-C18: First-in-Human Clinical Trial of ABTL0812, a Compound that Inhibits PI3K/Akt/mTOR Pathway by Upregulating TRIB3, in Patients with Advanced Solid Tumors

Laura Vidal, Lydia Gaba, Ivan Victoria, Marta Gil-Martin, Berta Laquente, Marc Cortal, Merce Brunet, Pilar Paredes, Mariana Gomez-Ferreria, Jose Alfon, Carles Domenech, Pedro Gascon
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): LB-C18.
https://doi.org/10.1158/1535-7163.TARG-15-LB-C18
Published: 01 December 2015
View article titled, Abstract LB-C18: First-in-Human Clinical Trial of ABTL0812, a Compound that Inhibits PI3K/Akt/mTOR Pathway by Upregulating TRIB3, in Patients with Advanced Solid Tumors
Journal Articles

Abstract A150: A methodology for the isolation, culture, and immortalization of human breast epithelial and myoepithelial cells.

Gemma Fuster, Arantzazu Zubeldia-Plazaola, Mario Mancino, Patricia Fernández-Nogueira, Elisabet Ametller, Pedro Gascón, Vanessa Almendro
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A150.
https://doi.org/10.1158/1535-7163.TARG-13-A150
Published: 01 November 2013
View article titled, Abstract A150: A methodology for the isolation, culture, and immortalization of human breast epithelial and myoepithelial cells.
Journal Articles

Abstract A60: Activation of compensatory receptor tyrosine kinases after the acquisition of resistance to anti-Her2 therapies.

Patricia Fernandez Nogueira, Anke Bill, Inga Rye, Domiziana Costamagna, Hege Russnes, Pedro Gascón, Alex Gaither, Vanessa Almendro
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A60.
https://doi.org/10.1158/1535-7163.TARG-13-A60
Published: 01 November 2013
View article titled, Abstract A60: Activation of compensatory receptor tyrosine kinases after the acquisition of resistance to anti-Her2 therapies.
Journal Articles

Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer

Mercedes Marín-Aguilera, Jordi Codony-Servat, Susana G. Kalko, Pedro L. Fernández, Raquel Bermudo, Elvira Buxo, María José Ribal, Pedro Gascón, Begoña Mellado
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (2): 329–339.
https://doi.org/10.1158/1535-7163.MCT-11-0289
Published: 08 February 2012
View article titled, Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer
Open the PDF for Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data